⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IRON News
Disc Medicine, Inc. Common Stock
Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
globenewswire.com
IRON
Disc Medicine to Participate in Upcoming Investor Conferences
globenewswire.com
IRON
Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week
globenewswire.com
IRON
Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)
globenewswire.com
IRON
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
globenewswire.com
IRON